Cargando…

Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients

INTRODUCTION: Acid–base abnormalities are common in the intensive care unit (ICU). Differences in outcome exist between respiratory and metabolic acidosis in similar pH ranges. Some forms of metabolic acidosis (for example, lactate) seem to have worse outcomes than others (for example, chloride). Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunnerson, Kyle J, Saul, Melissa, He, Shui, Kellum, John A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550830/
https://www.ncbi.nlm.nih.gov/pubmed/16507145
http://dx.doi.org/10.1186/cc3987
_version_ 1782129283124166656
author Gunnerson, Kyle J
Saul, Melissa
He, Shui
Kellum, John A
author_facet Gunnerson, Kyle J
Saul, Melissa
He, Shui
Kellum, John A
author_sort Gunnerson, Kyle J
collection PubMed
description INTRODUCTION: Acid–base abnormalities are common in the intensive care unit (ICU). Differences in outcome exist between respiratory and metabolic acidosis in similar pH ranges. Some forms of metabolic acidosis (for example, lactate) seem to have worse outcomes than others (for example, chloride). The relative incidence of each type of disorder is unknown. We therefore designed this study to determine the nature and clinical significance of metabolic acidosis in critically ill patients. METHODS: An observational, cohort study of critically ill patients was performed in a tertiary care hospital. Critically ill patients were selected on the clinical suspicion of the presence of lactic acidosis. The inpatient mortality of the entire group was 14%, with a length of stay in hospital of 12 days and a length of stay in the ICU of 5.8 days. RESULTS: We reviewed records of 9,799 patients admitted to the ICUs at our institution between 1 January 2001 and 30 June 2002. We selected a cohort in which clinicians caring for patients ordered a measurement of arterial lactate level. We excluded patients in which any necessary variable required to characterize an acid–base disorder was absent. A total of 851 patients (9% of ICU admissions) met our criteria. Of these, 548 patients (64%) had a metabolic acidosis (standard base excess < -2 mEq/l) and these patients had a 45% mortality, compared with 25% for those with no metabolic acidosis (p < 0.001). We then subclassified metabolic acidosis cases on the basis of the predominant anion present (lactate, chloride, or all other anions). The mortality rate was highest for lactic acidosis (56%); for strong ion gap (SIG) acidosis it was 39% and for hyperchloremic acidosis 29% (p < 0.001). A stepwise logistic regression model identified serum lactate, SIG, phosphate, and age as independent predictors of mortality. CONCLUSION: In critically ill patients in which a measurement of lactate level was ordered, lactate and SIG were strong independent predictors of mortality when they were the major source of metabolic acidosis. Overall, patients with metabolic acidosis were nearly twice as likely to die as patients without metabolic acidosis.
format Text
id pubmed-1550830
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15508302006-08-22 Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients Gunnerson, Kyle J Saul, Melissa He, Shui Kellum, John A Crit Care Research INTRODUCTION: Acid–base abnormalities are common in the intensive care unit (ICU). Differences in outcome exist between respiratory and metabolic acidosis in similar pH ranges. Some forms of metabolic acidosis (for example, lactate) seem to have worse outcomes than others (for example, chloride). The relative incidence of each type of disorder is unknown. We therefore designed this study to determine the nature and clinical significance of metabolic acidosis in critically ill patients. METHODS: An observational, cohort study of critically ill patients was performed in a tertiary care hospital. Critically ill patients were selected on the clinical suspicion of the presence of lactic acidosis. The inpatient mortality of the entire group was 14%, with a length of stay in hospital of 12 days and a length of stay in the ICU of 5.8 days. RESULTS: We reviewed records of 9,799 patients admitted to the ICUs at our institution between 1 January 2001 and 30 June 2002. We selected a cohort in which clinicians caring for patients ordered a measurement of arterial lactate level. We excluded patients in which any necessary variable required to characterize an acid–base disorder was absent. A total of 851 patients (9% of ICU admissions) met our criteria. Of these, 548 patients (64%) had a metabolic acidosis (standard base excess < -2 mEq/l) and these patients had a 45% mortality, compared with 25% for those with no metabolic acidosis (p < 0.001). We then subclassified metabolic acidosis cases on the basis of the predominant anion present (lactate, chloride, or all other anions). The mortality rate was highest for lactic acidosis (56%); for strong ion gap (SIG) acidosis it was 39% and for hyperchloremic acidosis 29% (p < 0.001). A stepwise logistic regression model identified serum lactate, SIG, phosphate, and age as independent predictors of mortality. CONCLUSION: In critically ill patients in which a measurement of lactate level was ordered, lactate and SIG were strong independent predictors of mortality when they were the major source of metabolic acidosis. Overall, patients with metabolic acidosis were nearly twice as likely to die as patients without metabolic acidosis. BioMed Central 2006 2006-02-10 /pmc/articles/PMC1550830/ /pubmed/16507145 http://dx.doi.org/10.1186/cc3987 Text en Copyright © 2006 Gunnerson et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Gunnerson, Kyle J
Saul, Melissa
He, Shui
Kellum, John A
Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients
title Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients
title_full Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients
title_fullStr Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients
title_full_unstemmed Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients
title_short Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients
title_sort lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550830/
https://www.ncbi.nlm.nih.gov/pubmed/16507145
http://dx.doi.org/10.1186/cc3987
work_keys_str_mv AT gunnersonkylej lactateversusnonlactatemetabolicacidosisaretrospectiveoutcomeevaluationofcriticallyillpatients
AT saulmelissa lactateversusnonlactatemetabolicacidosisaretrospectiveoutcomeevaluationofcriticallyillpatients
AT heshui lactateversusnonlactatemetabolicacidosisaretrospectiveoutcomeevaluationofcriticallyillpatients
AT kellumjohna lactateversusnonlactatemetabolicacidosisaretrospectiveoutcomeevaluationofcriticallyillpatients